Newsquawk Logo

The FDA tells Novo Nordisk (NOVOB DC) that its Wegovy AD is false or misleading

The FDA's warning to Novo Nordisk regarding its Wegovy advertising could have significant implications for the company's marketing strategy and public perception.

Newsquawk StaffPublished On the live feed at — 3 more headlines followed before this page went public
Newsquawk headlinesUTC

SBI is reportedly working with State Street (STT) on a US energy fund to invest in relevant ETFs, Nikkei reports; aiming to have AUMs of JPY 100bln AUM in the next three years

Pentagon announces that US forces seized an oil tanker departing from Venezuela, via Al Arabiya

The FDA tells Novo Nordisk (NOVOB DC) that its Wegovy AD is false or misleading

[MARKET ANALYSIS] UK assets in focus as scrutiny around PM Starmer heightens, however, the support of most of his Cabinet favours in favour of the narrative that he will remain until at least the May local elections

UK Labour MP Streeting says PM Starmer does not need to resign, Sky News' Rigby reports; says "give Keir a chance"

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

This regulatory scrutiny may hinder sales and affect Novo's stock performance within the consumer staples sector, particularly in European markets, where clarity on advertising standards is crucial for maintaining consumer trust.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.